Back to LYEL
JANE STREET GROUP, LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
10
Latest value
$345K
Q3 2026
Peak value
$2.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $238K |
| Q4 2025 | $144K |
| Q1 2026 | $994K |
| Q1 2026 | $288K |
| Q2 2026 | $476K |
| Q2 2026 | $170K |
| Q3 2026 | $147K |
| Q3 2026 | $2.2M |
| Q3 2026 | $12K |
| Q3 2026 | $345K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $345K | 35.2K | — | — |
| Q3 2026 | $12K | 1.3K | — | — |
| Q3 2026 | $2.2M | 219.8K | — | — |
| Q3 2026 | $147K | 15.0K | — | — |
| Q2 2026 | $170K | 12.1K | — | — |
| Q2 2026 | $476K | 33.9K | — | — |
| Q1 2026 | $288K | 14.4K | — | — |
| Q1 2026 | $994K | 49.5K | — | — |
| Q4 2025 | $144K | 4.7K | — | — |
| Q4 2025 | $238K | 7.7K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M